Illumina partners with Singapore for whole genome sequencing research initiative
November 04, 2026 | 09:19
Biotechnology firm Illumina secured a selection to support the SG-INSIGHT clinical study, expanding whole-genome sequencing coverage to nearly ten per cent of Singapore residents.
Mobile Version